Roche Gets Second Chance In Accutane Liability Suit; Pre-emption Still Possible

A New Jersey appeals court vacated a $2.6 million jury verdict against Roche and ordered a new trial to determine if its acne drug Accutane (isotretinoin) caused a plaintiff's inflammatory bowel disease

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet